Monoclonals Inc.

Developing novel monoclonal antibodies for rapid tests which diagnose diseases, specifically for resource poor areas.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Ellsworth, ME, US
  • Currency USD
  • Founded April 2016
  • Employees 2
  • Incorporation Type C-corp
  • Website monoclonalsin.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free